(19)
(11) EP 4 583 864 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23767845.3

(22) Date of filing: 05.09.2023
(51) International Patent Classification (IPC): 
A61K 31/381(2006.01)
A61P 13/12(2006.01)
A61K 31/55(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/55; A61K 31/381; A61P 13/12
(86) International application number:
PCT/EP2023/074334
(87) International publication number:
WO 2024/052350 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 06.09.2022 EP 22306320

(71) Applicants:
  • Institut National de la Santé et de la Recherche Médicale
    75013 Paris (FR)
  • Centre Hospitalier Universitaire de Rouen
    76000 Rouen (FR)
  • Université de Rouen Normandie
    76130 Mont-Saint-Aignan (FR)

(72) Inventors:
  • BELLIEN, Jérémy
    76183 Rouen cedex (FR)
  • GUERROT, Dominique
    76183 Rouen Cedex (FR)

(74) Representative: Inserm Transfert 
PariSanté Campus 10 rue d'Oradour-sur-Glane
75015 Paris
75015 Paris (FR)

   


(54) METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING D1-LIKE DOPAMINE RECEPTOR AGONIST FOR THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE